PCS
KNSA icon

Personal CFO Solutions’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Personal CFO Solutions’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,238
Closed -$356K – 553
2024
Q3 		$356K Hold
14,238
– – 0.05% 350
2024
Q2 		$266K Hold
14,238
– – 0.04% 425
2024
Q1 		$281K Hold
14,238
– – 0.04% 416
2023
Q4 		$250K Hold
14,238
– – 0.04% 423
2023
Q3 		$247K Hold
14,238
– – 0.05% 378
2023
Q2 		$200K Hold
14,238
– – 0.04% 447
2023
Q1 		$153K Hold
14,238
– – 0.03% 456
2022
Q4 		$213K Hold
14,238
– – 0.05% 404
2022
Q3 		$183K Sell
14,238
-1,000
-7% -$11.4K 0.05% 383
2022
Q2 		$148K Sell
15,238
-2,000
-12% -$18.7K 0.03% 409
2022
Q1 		$171K Hold
17,238
– – 0.03% 445
2021
Q4 		$203K Sell
17,238
-5,000
-22% -$61.4K 0.04% 442
2021
Q3 		$253K Sell
22,238
-4,300
-16% -$56K 0.05% 352
2021
Q2 		$370K Buy
26,538
+300
+1% +$4.56K 0.08% 236
2021
Q1 		$486K Hold
26,238
– – 0.11% 181
2020
Q4 		$464K Buy
26,238
+4,538
+21% +$79.7K 0.11% 177
2020
Q3 		$0 Buy
21,700
+2,000
+10% +$37.5K ﹤0.01% 245
2020
Q2 		$502K Hold
19,700
– – 0.15% 128
2020
Q1 		$305K Buy
+19,700
New +$308K 0.11% 169

Other funds holding KNSA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Personal CFO Solutions's KNSA Position: Q4 2024 in Review

Personal CFO Solutions sold out of Kiniksa Pharmaceuticals (KNSA) in Q4 2024, closing a stake of 14,238 shares — an estimated $356K sold.

Personal CFO Solutions first reported a position in KNSA in Q1 2020 and held it in 19 quarters. The position peaked at $502K in Q2 2020. 160 funds tracked by Wall St. Rank hold KNSA as of Q4 2024.

  • Personal CFO Solutions reported no remaining Kiniksa Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Personal CFO Solutions sold 14,238 Kiniksa Pharmaceuticals shares in Q4 2024, an estimated $356K.
  • Personal CFO Solutions first reported a position in Kiniksa Pharmaceuticals in Q1 2020 and held it in 19 quarters.
  • Personal CFO Solutions's Kiniksa Pharmaceuticals position peaked at $502K in Q2 2020.
  • 160 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q4 2024.

Based on Personal CFO Solutions's 13F filing for Q4 2024, filed 7 Feb 2025.